FDA — authorised 29 April 1952
- Application: NDA008372
- Marketing authorisation holder: MALLINCKRODT IRELAND
- Local brand name: ACTHAR GEL (AUTOINJECTOR)
- Indication: INJECTABLE — INJECTION
- Status: approved
FDA authorised ACTH on 29 April 1952
Yes. FDA authorised it on 29 April 1952; FDA authorised it on 16 June 1954; FDA authorised it on 12 September 1957.
MALLINCKRODT IRELAND holds the US marketing authorisation.